Dr. Priya Agrawal

Dr. Priya Agrawal, MD (BMBCh), MPH is Vice President of Health Equity and Partnerships at Merck (MSD), where she leads global efforts to advance equitable access to healthcare across low- and middle-income countries through partnerships, innovation, and systems strengthening. Previously, she served as Global Head of HPV Vaccines at Merck, overseeing a multibillion-dollar portfolio and working closely with the WHO to advance the global goal of eliminating cervical cancer. A physician and public health leader, Dr. Agrawal has held senior roles across industry, government, and multilaterals, including the World Health Organization, and serves on multiple global health boards.